GRACE LIFE-TECH (02112) announced its interim results for 2025, reporting revenue of US$8.417 million, representing a 41% year-on-year increase. The company recorded a profit attributable to owners of the parent company of US$211,000, compared to a loss of US$8.966 million in the same period last year. Basic earnings per share stood at 0.01 US cents. The increase in sales revenue during the period was attributed to the expansion of plant stem cell sales channels and growth in customer base.